Research Paper Advance Articles

LncRNA AC079630.4 expression associated with the progression and prognosis in lung cancer

Experimental validation of the effects of AC079630.4 over-expression on lung cancer cells. (A) Transfection efficiency of AC079630.4 over-expression plasmid. (B) Survival curves of transfected cells with AC079630.4 over-expression plasmid (pcDNA3.1-AC079630.4) or the negative control (pcDNA3.1-NC). (C) Cell proliferation assay analysis of transfected cells with AC079630.4 over-expression plasmid or the negative control. (D) Effect of AC079630.4 over-expression on the expression of TRAIL-R1 and TRAIL-R2. *PPP

Figure 6. Experimental validation of the effects of AC079630.4 over-expression on lung cancer cells. (A) Transfection efficiency of AC079630.4 over-expression plasmid. (B) Survival curves of transfected cells with AC079630.4 over-expression plasmid (pcDNA3.1-AC079630.4) or the negative control (pcDNA3.1-NC). (C) Cell proliferation assay analysis of transfected cells with AC079630.4 over-expression plasmid or the negative control. (D) Effect of AC079630.4 over-expression on the expression of TRAIL-R1 and TRAIL-R2. *P<0.05, **P<0.01, ***P<0.001.